125 related articles for article (PubMed ID: 2956609)
1. Role of atrial natriuretic peptide in mineralocorticoid escape phenomenon in patients with primary aldosteronism.
Nakamura T; Ichikawa S; Sakamaki T; Sato K; Kogure M; Tajima Y; Kato T; Murata K
Proc Soc Exp Biol Med; 1987 Sep; 185(4):448-54. PubMed ID: 2956609
[TBL] [Abstract][Full Text] [Related]
2. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
Sakamoto H; Ichikawa S; Sakamaki T; Nakamura T; Ono Z; Takayama Y; Murata K
Am J Hypertens; 1990 Jul; 3(7):533-7. PubMed ID: 2194510
[TBL] [Abstract][Full Text] [Related]
3. Sodium excretion and atrial natriuretic peptide levels during mineralocorticoid administration. A mechanism for the escape from hyperaldosteronism.
Kelly TM; Nelson DH
Endocr Res; 1987; 13(4):363-83. PubMed ID: 2966064
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects.
Rocco S; Opocher G; Carpenè G; Mantero F
Am J Hypertens; 1990 Sep; 3(9):668-73. PubMed ID: 2145872
[TBL] [Abstract][Full Text] [Related]
5. The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism.
Nakada T; Furuta H; Katayama T; Sumiya H; Shimazaki J
J Urol; 1989 Jul; 142(1):13-8. PubMed ID: 2525199
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide during mineralocorticoid escape in the human.
Zimmerman RS; Edwards BS; Schwab TR; Heublein DM; Burnett JC
J Clin Endocrinol Metab; 1987 Mar; 64(3):624-7. PubMed ID: 2950127
[TBL] [Abstract][Full Text] [Related]
7. Hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension.
Hirata Y; Ishii M; Sugimoto T; Matsuoka H; Fukui K; Sugimoto T; Yamakado M; Tagawa H; Miyata A; Kangawa K
Circulation; 1988 Dec; 78(6):1401-10. PubMed ID: 2847885
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
Hensen J; Abraham WT; Dürr JA; Schrier RW
Am J Nephrol; 1991; 11(6):441-6. PubMed ID: 1840232
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism.
Sergev O; Rácz K; Varga I; Kiss R; Fütö L; Gutkowska J; Gláz E
Clin Exp Hypertens A; 1991; 13(3):409-23. PubMed ID: 1832596
[TBL] [Abstract][Full Text] [Related]
10. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.
Ichikawa S; Tajima Y; Sakamaki T; Matsuo H; Kogure M; Hirano Y; Yagi S; Murata K
Jpn Circ J; 1984 Nov; 48(11):1184-96. PubMed ID: 6502914
[TBL] [Abstract][Full Text] [Related]
11. Potassium supplementation improves the natriuretic response to central volume expansion in primary aldosteronism.
Coruzzi P; Gualerzi M; Parati G; Brambilla L; Brambilla V; Di Rienzo M; Novarini A
Metabolism; 2003 Dec; 52(12):1597-600. PubMed ID: 14669162
[TBL] [Abstract][Full Text] [Related]
12. Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
Coruzzi P
J Clin Endocrinol Metab; 1994 Feb; 78(2):455-8. PubMed ID: 8106635
[TBL] [Abstract][Full Text] [Related]
13. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide.
Trevisani F; Colantoni A; Sica G; Gasbarrini A; D'Intino PE; De Notariis S; De Jaso R; Barbieri A; Morselli A; Gasbarrini G
Hepatology; 1995 Jul; 22(1):132-7. PubMed ID: 7601404
[TBL] [Abstract][Full Text] [Related]
14. Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
Selçuk Y; San A; Bakan E; Yiğitoğlu R
Nephrol Dial Transplant; 1991; 6(8):557-61. PubMed ID: 1835523
[TBL] [Abstract][Full Text] [Related]
15. Volume-pressure relationships during development of mineralocorticoid hypertension in man.
Wenting GH; Man in 't Veld AJ; Verhoeven RP; Derkx FH; Schalekamp DH
Circ Res; 1977 May; 40(5 Suppl 1):I163-70. PubMed ID: 858175
[TBL] [Abstract][Full Text] [Related]
16. Plasma atrial natriuretic peptide (ANP) in primary aldosteronism.
Chen JH; Tsai JH; Lai YH; Hwang SJ
Taiwan Yi Xue Hui Za Zhi; 1988 Sep; 87(9):851-6. PubMed ID: 2975697
[No Abstract] [Full Text] [Related]
17. Atrial natriuretic peptide: physiological release associated with natriuresis during negative pressure breathing in man.
Anderson JV; Maxwell DL; Payne NN; Slater JD; Bloom SR
Clin Sci (Lond); 1989 Apr; 76(4):423-9. PubMed ID: 2523770
[TBL] [Abstract][Full Text] [Related]
18. Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension.
Colantonio D; Casale R; Desiati P; Giandomenico G; Bucci V; Pasqualetti P
J Clin Pharmacol; 1991 Mar; 31(3):238-42. PubMed ID: 1826912
[TBL] [Abstract][Full Text] [Related]
19. Alpha-h-ANP injection in normals, low renin hypertension and primary aldosteronism.
Mantero F; Rocco S; Pertile F; Carpené G; Fallo F; Menegus A
J Steroid Biochem; 1987; 27(4-6):935-40. PubMed ID: 2961943
[TBL] [Abstract][Full Text] [Related]
20. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
Lan NC; Matulich DT; Stockigt JR; Biglieri EG; New MI; Winter JS; McKenzie JK; Baxter JD
Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
